Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$60.18

-1.03 (-1.68%)

, PFE

Pfizer

$35.79

-0.16 (-0.45%)

07:16
04/12/18
04/12
07:16
04/12/18
07:16

Bristol-Myers price target lowered to $70 from $78 at Citi

Citi analyst Andrew Baum lowered his price target for Bristol-Myers Squibb (BMY) to $70 after Pfizer (PFE) management made clear to him that they had no interest in acquiring Bristol without transformational data or a de-rating in the shares. The analyst removed the $8 per share risk adjusted M&A premium from his Bristol-Myers target price. He views his new price target as conservative, however, and keeps a Buy rating on the name.

BMY

Bristol-Myers

$60.18

-1.03 (-1.68%)

PFE

Pfizer

$35.79

-0.16 (-0.45%)

  • 14

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 08

    May

  • 05

    Jun

  • 10

    Jul

BMY Bristol-Myers
$60.18

-1.03 (-1.68%)

03/20/18
JPMS
03/20/18
NO CHANGE
Target $75
JPMS
Overweight
Bristol-Myers price target raised to $75 from $70 at JPMorgan
JPMorgan analyst Chris Schott raised his price target for Bristol-Myers Squibb to $75 saying the company's opportunity in non-lung tumor types is broad and underappreciated. The analyst sees a number of $1B-plus indications for Opdivo beyond non-small-cell lung carcinoma, including kidney, liver, gastric, small cell lung and melanoma. These indications should represent the majority of Opdivo sales over time, Schott tells investors in a research note. The analyst keeps an Overweight rating on Bristol-Myers.
04/06/18
MZHO
04/06/18
NO CHANGE
Target $103
MZHO
Buy
Mizuho says failure of Incyte's epacadostat ups chances of Nektar takeover
Mizuho analyst Difei Yang raised her price target on Nektar Therapeutics (NKTR) to $103 from $89 after Incyte (INCY) announced this morning the failure of epacadostat in combination with Merck's (MRK) Keytruda in a phase 3 study in melanoma patients. Recent clinical data presented by Nektar reinforced her view of NKTR-214 as one of the most impressive combo agent for checkpoint inhibitors, said Yang, who believes that the failure of epacadostat raises the possibility of a takeout by Bristol-Myers (BMY) in the coming months. She maintains a Buy rating on Nektar shares, which are down 8.5% to $92.75 in afternoon trading.
04/09/18
HCWC
04/09/18
NO CHANGE
Target $125
HCWC
Buy
Nektar data 'more robust' than Incyte's, says H.C. Wainwright
The failure of Incyte (INCY) and Merck's (MRK) Phase 3 study negatively impacted trading in Nektar Therapeutics (NKTR) shares on Friday, H.C. Wainwright analyst Debjit Chattopadhyay tells investors in a research note titled "Collateral Damage Not Surprising; Expecting ASCO-18 to Validate the Master T Cell Regulator Hypothesis." At this year's American Society of Clinical Oncology meeting, the analyst expects Nektar and partner Bristol-Myers Squibb (BMY) to unveil data from at least 40 advanced melanoma patients "supported by in-depth biomarker characterization to comprehensively ascertain the rationale of combining NKTR-214 with Opdivo." The rationale for combining NKTR-214 with Opdivo is "more robust" than epacadostat plus Keytruda, the analyst contends. Further, he believes data generated by the NKTR-214 plus Opdivo combination is "unambiguous." Chattopadhyay reiterates a Buy rating on Nektar shares with a $125 price target.
04/12/18
SBSH
04/12/18
NO CHANGE
SBSH
Sell
Pfizer has no interest in acquiring Bristol-Myers right now, says Citi
Citi analyst Andrew Baum says Pfizer's (PFE) CEO made it clear to him that the company has no interest in acquiring Bristol-Myers Squibb (BMY) in the absence of transformational data or a de-rating in the shares. Pfizer has high conviction in its current pipeline and believes that the return on investment is considerably higher than high risk transformational deals, particularly in the immuno-oncology space, Baum tells investors in a research note. The analyst expects Pfizer will meaningfully increase its current share repurchase program from the current $5B-$6B per annum to offset the earnings dilution from higher anticipated R&D investment to monetize its current pipeline. Baum keeps a Sell rating on Pfizer and continues to prefer shares of Merck (MRK), Bristol and Eli Lilly (LLY) in the U.S. The analyst lowered his price target for Bristol shares to $70 from $78 with Pfizer backing away from a potential takeover. He keeps a Buy rating on the shares, however.
PFE Pfizer
$35.79

-0.16 (-0.45%)

04/05/18
LEHM
04/05/18
DOWNGRADE
Target $38
LEHM
Equal Weight
Pfizer downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Geoffrey Meacham downgraded Pfizer to Equal Weight and lowered his price target for the shares to $38 from $41. The analyst believes the stock at current levels largely capture the upside for key products like Prevnar, Ibrance, Xeljanz and Xtandi. He believes a transformative acquisition to accelerate Pfizer's growth is now less likely in the near term.
04/05/18
LEHM
04/05/18
NO CHANGE
LEHM
Barclays upgrades Merck, downgrades Biogen and Pfizer in sector reassessment
Barclays analyst Geoff Meacham made some rating changes while reassessing the Biopharmaceutical sector. Biopharma sentiment has been negative since the start of 2018, despite a modest pick-up in deals and diminished rhetoric on drug pricing, Meacham tells investors in a research note titled "U.S. Biopharmaceuticals: Where to from here?" The analyst believes "more transformative" acquisitions, "clean" Phase 3 wins, and even a relatively strong Q1 earnings season could help "re-rate the sector" and get investors more engaged in the group. Ahead of the Q1 earnings season, Meacham upgraded Merck (MRK) to Overweight from Equal Weight and downgraded to Equal Weight from Overweight shares of Biogen (BIIB), Pfizer (PFE), Biohaven Pharmaceutical (BHVN) and Myovant Sciences (MYOV). The analyst also lowered his price target for Equal Weight-rated AbbVie (ABBV) to $102 from $120, for Equal Weight-rated Amgen (AMGN) to $180 from $180, for Overweight-rated Prothena (PRTA) to $50 from $70 and for Overweight-rated Incyte (INCY) to $135 from $165.
04/05/18
04/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Hold from Buy at Stifel with analyst Kevin Cassidy citing the peaking server central processing unit cycle and valuation for the downgrade. 2. Johnson Controls (JCI) downgraded to Underperform from Sector Perform at RBC Capital with analyst Deane Dray citing the company's exposure to additional cash flow pressures in fiscal 2018, reduction in fiscal 2020 targets, and a market rotation toward "more defensive names." 3. Ryder (R) downgraded to Underweight from Neutral at JPMorgan with analyst Brian Ossenbeck saying he is making a "longer term call on 2019 expectations," which he believes are too high and embed "significant gains on residual values and used truck sales." 4. Ollie's Bargain Outlet (OLLI) downgraded to Neutral from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying valuation is getting "richer," quarterly comps have been decelerating since 2015, and are now expected to be 1%-2% in 2018. 5. Biogen (BIIB), Pfizer (PFE), Biohaven (BHVN), and Myovant Sciences (MYOV) were downgraded to Equal Weight from Overweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

04:55
04/21/18
04/21
04:55
04/21/18
04:55
Conference/Events
International Monetary Fund & World Bank Group to co-host an annual meeting »

2018 Spring Meeting will…

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

18:08
04/20/18
04/20
18:08
04/20/18
18:08
Periodicals
North Korea to suspend nuclear and ICBM tests, Bloomberg reports »

North Korea also plans to…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADM

Archer Daniels

$45.50

-0.295 (-0.64%)

, BG

Bunge

$73.72

-1.935 (-2.56%)

18:03
04/20/18
04/20
18:03
04/20/18
18:03
Periodicals
Archer Daniels, Bunge talks end without merger deal, Bloomberg reports »

Advanced merger…

ADM

Archer Daniels

$45.50

-0.295 (-0.64%)

BG

Bunge

$73.72

-1.935 (-2.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 30

    May

CE

Celanese

$111.69

0.56 (0.50%)

18:02
04/20/18
04/20
18:02
04/20/18
18:02
Hot Stocks
Celanese announces price increases in Asia »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 30

    May

IOTS

Adesto Technologies

$8.65

-0.2 (-2.26%)

17:33
04/20/18
04/20
17:33
04/20/18
17:33
Hot Stocks
Breaking Hot Stocks news story on Adesto Technologies »

180 Degree Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SIGM

Sigma Designs

$6.30

0.1 (1.61%)

17:22
04/20/18
04/20
17:22
04/20/18
17:22
Hot Stocks
Sigma Designs to delay filing Annual Report on Form 10-K »

Sigma Designs is unable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRK.A

Berkshire Hathaway

$300,140.00

-260 (-0.09%)

, BRK.B

Berkshire Hathaway

$200.09

-0.32 (-0.16%)

17:22
04/20/18
04/20
17:22
04/20/18
17:22
Hot Stocks
Breaking Hot Stocks news story on Berkshire Hathaway, Berkshire Hathaway, Torchmark »

Berkshire Hathaway…

BRK.A

Berkshire Hathaway

$300,140.00

-260 (-0.09%)

BRK.B

Berkshire Hathaway

$200.09

-0.32 (-0.16%)

TMK

Torchmark

$87.22

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMHI

SEACOR Marine Holdings

$22.90

-0.86 (-3.62%)

, CG

Carlyle Group

$20.85

0.15 (0.72%)

17:17
04/20/18
04/20
17:17
04/20/18
17:17
Syndicate
SEACOR Marine Holdings announces $56.9M private placement of common stock »

SEACOR Marine Holdings…

SMHI

SEACOR Marine Holdings

$22.90

-0.86 (-3.62%)

CG

Carlyle Group

$20.85

0.15 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

AVAV

AeroVironment

$56.66

-0.15 (-0.26%)

17:12
04/20/18
04/20
17:12
04/20/18
17:12
Hot Stocks
AeroVironment awarded $44.7M U.S. Army contract modification »

AeroVironment was awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

XLE

Energy Select Sector SPDR

$73.30

-0.36 (-0.49%)

, XLU

Utilities SPDR

$50.29

-0.45 (-0.89%)

17:10
04/20/18
04/20
17:10
04/20/18
17:10
General news
Week ending ETF Scorecard: Energy outperforms again, Staples lag »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$73.30

-0.36 (-0.49%)

XLU

Utilities SPDR

$50.29

-0.45 (-0.89%)

IYR

DJ US Real Estate Index Fund

$73.94

-0.62 (-0.83%)

XLP

Consumer Staples Sector SPDR

$50.49

-0.85 (-1.66%)

XLY

Consumer Discretionary Sector SPDR

$102.97

-1.06 (-1.02%)

XLB

S&P Select Materials SPDR

$59.00

-0.36 (-0.61%)

XLF

Financial Select Sector

$27.89

0.015 (0.05%)

XLV

Health Care Select Sector SPDR

$82.10

-0.45 (-0.55%)

XLK

Technology Select Sector SPDR

$66.18

-0.97 (-1.44%)

XLI

Industrial Select Sector SPDR

$75.59

-0.32 (-0.42%)

GLD

SPDR Gold Trust

$126.61

-1.01 (-0.79%)

SLV

iShares Silver Trust

$16.14

-0.11 (-0.68%)

USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

UNG

United States Natural Gas Fund

$22.56

0.475 (2.15%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.91

-0.19 (-0.22%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.47

-0.49 (-0.42%)

TLT

iShares 20+ Year Treasury Bond Fund

$118.47

-0.88 (-0.74%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.57

-0.355 (-0.35%)

SHY

iShares 1-3 Year Treasury Bond

$83.26

-0.03 (-0.04%)

IWD

iShares Russell 1000 Value

$121.38

-0.61 (-0.50%)

IWF

iShares Russell 1000 Growth

$137.65

-1.53 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.16

-0.0051 (-3.02%)

17:07
04/20/18
04/20
17:07
04/20/18
17:07
Syndicate
Breaking Syndicate news story on Jaguar Health »

Jaguar Health files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$86.98

-0.9 (-1.02%)

, FB

Facebook

$166.29

-1.82 (-1.08%)

17:05
04/20/18
04/20
17:05
04/20/18
17:05
Hot Stocks
Walmart says Kevin Systrom will not stand for re-election to board »

Walmart and Systrom, the…

WMT

Walmart

$86.98

-0.9 (-1.02%)

FB

Facebook

$166.29

-1.82 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 25

    Apr

  • 17

    May

  • 30

    May

  • 01

    Jun

WMT

Walmart

$86.98

-0.9 (-1.02%)

, MCD

McDonald's

$158.77

-0.76 (-0.48%)

17:03
04/20/18
04/20
17:03
04/20/18
17:03
Hot Stocks
Walmart announces McDonald's Steve Easterbrook as independent nominee to board »

"This year's…

WMT

Walmart

$86.98

-0.9 (-1.02%)

MCD

McDonald's

$158.77

-0.76 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 30

    Apr

  • 17

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 01

    Jun

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

, USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

17:00
04/20/18
04/20
17:00
04/20/18
17:00
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 2.5K…

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

GLD

SPDR Gold Trust

$126.61

-1.01 (-0.79%)

FXE

Euro Currency Trust

$118.04

-0.65 (-0.55%)

FXC

CurrencyShares Canadian Dollar Trust

$77.37

-0.54 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXR

Citius Pharmaceuticals

$2.86

0.01 (0.35%)

16:59
04/20/18
04/20
16:59
04/20/18
16:59
Syndicate
Breaking Syndicate news story on Citius Pharmaceuticals »

Citius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
04/20/18
04/20
16:55
04/20/18
16:55
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

FPI

Farmland Partners

$7.85

-0.24 (-2.97%)

16:51
04/20/18
04/20
16:51
04/20/18
16:51
Syndicate
Breaking Syndicate news story on Farmland Partners »

Farmland Partners files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIFI

Gulf Island Fabrication

$8.85

0.05 (0.57%)

16:51
04/20/18
04/20
16:51
04/20/18
16:51
Hot Stocks
Breaking Hot Stocks news story on Gulf Island Fabrication »

PVAM Perlus Microcap Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 27

    Apr

AMID

American Midstream Partners

$11.45

-0.1 (-0.87%)

16:46
04/20/18
04/20
16:46
04/20/18
16:46
Syndicate
American Midstream Partners files $150M preferred unit offering »

The offering is for $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMID

American Midstream Partners

$11.45

-0.1 (-0.87%)

16:41
04/20/18
04/20
16:41
04/20/18
16:41
Syndicate
American Midstream Partners requests withdrawal of registration statement »

The Partnership has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSC

Seven Stars Cloud Group

$2.67

-0.1 (-3.61%)

16:40
04/20/18
04/20
16:40
04/20/18
16:40
Syndicate
Breaking Syndicate news story on Seven Stars Cloud Group »

Seven Stars Cloud Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:39
04/20/18
04/20
16:39
04/20/18
16:39
Hot Stocks
HNI Corporation CEO says 'seeing increased inflationary pressures' »

"We continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:38
04/20/18
04/20
16:38
04/20/18
16:38
Earnings
HNI Corporation narrows FY18 adjusted EPS view to $2.40-$2.70 from $2.40-$2.80 »

FY18 consensus $2.54. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:35
04/20/18
04/20
16:35
04/20/18
16:35
Earnings
HNI Corporation sees Q2 adjusted EPS 28c-38c ex-costs, consensus 56c »

Sees Q2 organic revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

WHR

Whirlpool

$149.43

-2.505 (-1.65%)

16:34
04/20/18
04/20
16:34
04/20/18
16:34
Syndicate
Breaking Syndicate news story on Whirlpool »

Whirlpool files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.